Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · IEX Real-Time Price · USD
26.54
-0.86 (-3.14%)
At close: May 1, 2024, 4:00 PM
26.88
+0.34 (1.28%)
After-hours: May 1, 2024, 7:52 PM EDT

Q32 Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
39.2733.99110.34218.7155.0539.9953.3511.67
Short-Term Investments
43.39141.0447.490208.61176.5278.080
Cash & Cash Equivalents
82.65175.03157.83218.71263.66216.51131.4311.67
Cash Growth
-52.78%10.90%-27.84%-17.05%21.78%64.73%1026.40%-
Other Current Assets
1.265.9934.080.862.925.180.170.32
Total Current Assets
83.91181.02191.91219.56266.58221.69131.611.99
Property, Plant & Equipment
0.6521.6417.8642.942.7235.643.151.96
Long-Term Investments
025.81000000
Other Long-Term Assets
001.951.271.271.772.770.28
Total Long-Term Assets
0.6547.4619.8144.1743.9937.415.932.23
Total Assets
84.56228.47211.72263.74310.57259.09137.5314.22
Accounts Payable
3.231.142.374.722.6115.732.540.89
Deferred Revenue
01.164.3637.7830.9531.5233.410
Current Debt
1.321.560.252.50000
Other Current Liabilities
7.0218.7210.25-22.34-21.19-24.73-27.095.48
Total Current Liabilities
11.5722.5817.2322.6612.3722.528.866.38
Long-Term Debt
027.9223.6912.940000
Other Long-Term Liabilities
001.1632.1439.6940.2230.360.34
Total Long-Term Liabilities
027.9224.8445.0839.6940.2230.360.34
Total Liabilities
11.5750.4942.0767.7452.0662.7439.226.72
Total Debt
1.3229.4823.9315.440000
Debt Growth
-95.53%23.16%54.99%-----
Retained Earnings
-542.1-429.14-424.13-328.37-199.67-95.76-40.18-10.19
Comprehensive Income
-0.01-0.4-0.0100.18-0.08-0.070
Shareholders' Equity
72.99177.98169.65196258.51196.36-39.45-9.89
Net Cash / Debt
81.34145.55133.89203.26263.66216.51131.4311.67
Net Cash / Debt Growth
-44.12%8.71%-34.13%-22.91%21.78%64.73%1026.40%-
Net Cash Per Share
25.3145.6443.5979.69112.68136.49954.15110.51
Working Capital
72.34158.44174.68196.91254.2199.17122.745.61
Book Value Per Share
22.7255.8155.2476.84110.48123.79-286.43-93.69
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).